Series CHealthNov 18, 2026

Isomorphic Labs raises $5.00B Series C (Nov 2026)

$5.00B
$5 billion

Find the investors funding Health Series C rounds

326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.

Find your investors →
Headline

Isomorphic Labs raises $5 billion in Series C to build out clinical development - XenoSpectrum

About

Isomorphic Labs is an AI-driven drug discovery company. It aims to accelerate the drug discovery and development process using artificial intelligence. This Series C funding will support the company's efforts to advance its clinical development pipeline.

Article summary

Isomorphic Labs raises $5 billion in Series C to build out clinical development  XenoSpectrum

Investors
Related rounds
Nov 19, 2026Aevius$22.0M——
Nov 18, 2026Celosia Therapeutics$2.0MGrantAustralia
Nov 17, 2026Mass General Brigham$22.0MSeedUnited States
Nov 17, 2026Treat$3.0M——

Find the investors behind rounds like this one

You just read who funded Isomorphic Labs. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.

Free account: 15 investor contact unlocks a month, no card required.

About the investors